Please login to the form below

Not currently logged in
Email:
Password:

Anoro Ellipta

This page shows the latest Anoro Ellipta news and features for those working in and with pharma, biotech and healthcare.

Sovaldi pushes Gilead to the top of US pharma list

Sovaldi pushes Gilead to the top of US pharma list

The London-based firm has also failed to increase market share for its next-gen versions of Advair - namely Breo, Ellipta and Anoro Ellipta - which had combined sales last year of

Latest news

  • GSK's Anoro first LAMA/LABA approved for COPD in US GSK's Anoro first LAMA/LABA approved for COPD in US

    GSK's Anoro first LAMA/LABA approved for COPD in US. Important step towards eventually replacing Seretide/Advair sales. ... GlaxoSmithKline's (GSK) chronic obstructive pulmonary disease (COPD) portfolio received a significant boost yesterday with the US

  • GSK’s COPD drug Anoro under review in US GSK’s COPD drug Anoro under review in US

    GSK’ s COPD drug Anoro under review in US. FDA accepts new drug application for the LAMA/LABA combination. ... GlaxoSmithKline's (GSK) investigational respiratory treatment Anoro is under review by the FDA after the US regulator accepted its new drug

More from news
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest appointments

  • Theravance hires BMS veteran Pasqualone Theravance hires BMS veteran Pasqualone

    Pasqualone joins Theravance as the company at a crucial time as its development deals with GlaxoSmithKline bears fruit with US approval of respiratory treatment Anoro Ellipta.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Anthill Agency

Anthill is a specialist digital agency and a strategic partner for life science companies....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics